Skip to main content
Premium Trial:

Request an Annual Quote

Malcolm Maltby, Philip Onigman, Cynthia Helphingstine, Patrick Carroll, Stelios Papadopoulos

Premium

Malcolm Maltby has become customer support manager for Farfield Sensors. He joins Farfield from Anachem, where he was responsible for maintenance and service of laboratory equipment. Also, Philip Onigman has joined SciPartners, Farfield Sensors’ US distributor, to help generate instrument sales in the US. He joins the company from Genzyme Transgenics, where he was director of marketing. Farfield, based in Salford, UK, sells instruments for the analysis of proteins and other molecules based on dual polarization interferometry.


Cynthia Helphingstine has become vice president of business development for Inproteo. Prior to joining Inproteo, Helphingstine was a consultant at Biotron Group, which she helped to found in 1986. She has also served as director of advanced product development at Baxter Healthcare, and in research positions at the University of Missouri School of Medicine.


Patrick Carroll has become the chief business officer of BioTrove. He joins the company from Applied Biosystems, where he was a senior vice president of worldwide sales. Carroll holds MS and BA degrees in biological sciences from the University of Delaware, as well as an MBA in marketing from Loyola College.


Stelios Papadopoulos has been appointed to the board of directors of Beyond Genomics. He is a vice chairman of SG Cowen Securities and covers biotechnology and the pharmaceutical industry as an investment banker. Papadopoulos holds a PhD in biophysics and an MBA in finance from New York University.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.